Picture of ISR Immune System Regulation Holding AB (publ) logo

ISR ISR Immune System Regulation Holding AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: ISR Enters Into LoI With Bumivac Ventures SDN BHD In Malaysia

Nov 2 (Reuters) - ISR Immune System Regulation Holding AB
(publ)  ISR.ST :
    * ENTERS INTO LOI WITH  BUMIVAC VENTURES SDN BHD IN MALAYSIA
    * LOI FOR DEVLOPMENT, DISTRIBUTION OF ISR'S NOSE SPRAY
VACCINE
AGAINST SARS-COV-2 VIRUS IN MALAYISA, OTHER AGREED COUNTRIES
    * BUMIVAC TO COMMITT TO FUND NECESSARY STUDIES TO PRODUCE
350,000
DOSES OF NASAL SPRAY VACCINE BY AUG 1, 2022, FOR PHASE III
CLINICAL TRIAL

Source text for Eikon:  ID:nWkr5MKl1W 
Further company coverage:  ISR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on ISR Immune System Regulation Holding AB (publ)

See all news